Results 41 to 50 of about 25,096,578 (256)

Therapeutic antibodies under development for SARS‐CoV‐2

View, 2022
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, Changhai Lei, Shi Hu   +7 more
doaj   +1 more source

SARS-CoV-2 surveillance in a hospital and control of an outbreak on a geriatric ward using whole genome sequencing

Infection Prevention in Practice
Summary: Background: During the SARS-CoV-2 pandemic, dominant viral variants were repeatedly replaced by new variants with altered properties, frequently changing the dynamics of the infection event, as well as the effectiveness of vaccines and ...
Hanno Schmidt, Niels Lemmermann, Matthias Linke, Sven-Ernö Bikár, Stefan Runkel, Susann Schweiger-Seemann, Susanne Gerber, André Michel, Thomas Hankeln, Marina Veith, Wolfgang Kohnen, Bodo Plachter   +11 more
doaj   +1 more source

Guillain‐Barré syndrome after SARS‐CoV‐2 infection

Journal of General and Family Medicine, 2022
We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita, Masamichi Sato, Yutaka Iizuka, Yamato Mashimo, Natsumi Furuta, Satoru Kakizaki   +5 more
doaj   +1 more source

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins

, 2020
Severe acute respiratory syndrome virus 2 (SARS-CoV-2) is responsible for the current global coronavirus disease 2019 (COVID-19) pandemic, infecting millions of people and causing hundreds of thousands of deaths.
Romain Gasser, Andrés Finzi, Marzena Pazgier, Cameron Abrams, Sai Anand, Guillaume Beaudoin-Bussières, Jérémie Prévost, Yaozong Chen   +7 more
core   +1 more source

Evaluation of EPISEQ SARS-CoV-2 and a Fully Integrated Application to Identify SARS-CoV-2 Variants from Several Next-Generation Sequencing Approaches

, 2022
Whole-genome sequencing has become an essential tool for real-time genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide.
Ligeon, Véronique, Emmanuelle Santiago, Vignola, Alexandre, Véronique Ligeon, Josset, Laurence, Regue, Hadrien, Abel Betraoui, Magali Jaillard, Griffon, Aurélien, Brengel-Pesce, Karen, Destras, Gregory, Tournoud, Maud, Nathalie Mugnier, Bal, Antonin, Maud Tournoud, Alexandre Vignola, Laurence Josset, Aurélien Griffon, Bruno Simon, Santiago, Emmanuelle, Gregory Destras, Jaillard, Magali, Karen Brengel-Pesce, Simon, Bruno, Antonin Bal, Mugnier, Nathalie, Maxence Rambaud, Cheynet, Valérie, Hadrien Regue, Valérie Cheynet, Betraoui, Abel, Rambaud, Maxence   +31 more
core   +1 more source

Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. [PDF]

, 2006
We systematically reviewed the current understanding of human population immunity against SARS-CoV in different groups, settings and geography. Our meta-analysis, which included all identified studies except those on wild animal handlers, yielded an ...
Donnelly, CA, Hedley, AJ, Ferguson, NM, Ho, LM, Lam, T-H, Ghani, AC, Anderson, RM, Lam, TH, Ho, L-M, Riley, S, Leung, GM, Fraser, C, Lim, WW   +12 more
core   +1 more source

Monitoring of SARS‐CoV‐2 infection in mustelids

EFSA Journal, 2021
American mink and ferret are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but no information is available for other mustelid species.
European Food Safety Authority and European Centre for Disease Prevention and Control, Anette Boklund, Christian Gortázar, Paolo Pasquali, Helen Roberts, Søren Saxmose Nielsen, Karl Stahl, Arjan Stegeman, Francesca Baldinelli, Alessandro Broglia, Yves Van Der Stede, Cornelia Adlhoch, Erik Alm, Angeliki Melidou, Grazina Mirinaviciute   +14 more
doaj   +1 more source

Biophysical approaches for studying viral entry

FEBS Letters, EarlyView.
Viruses infect all living organisms and have been responsible for major epidemics and pandemics. Their ongoing evolutionary battle with host defenses creates a constant need for improved tools to study viral behavior. Advancing methods to probe viral attachment, fusion, and genome release deepen our understanding of how infections begin and support the
Inbar Yosibash, Raya Sorkin
wiley   +1 more source

Aptamer‐based strategies against SARS‐CoV‐2 viruses

BMEMat, 2023
The COVID‐19 pandemic, caused by SARS‐CoV‐2, has seriously threatened human life and security in recent years and has had a serious impact on economic development. A range of strategies, including antibodies, small‐molecule agents and vaccines, have been
Yihao Huang, Ximing Chen, Jialu Zhang, Wenhai Tian, Siwen Liu, Rachel Chun‐Yee Tam, Chaoyong Yang, Yanling Song   +7 more
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

FEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang, Ruslana Romaniuk, Hristo L. Svilenov   +2 more
wiley   +1 more source